Implementing the MASH Care Pathway: An Interactive Case Challenge
Saturday, June 21st, 2025
Registration and Breakfast: 5:30 am CT
Presentation: 6:00 am - 7:30 am CT
OVERVIEW
The incidence of metabolic dysfunction-associated steatohepatitis (MASH) is growing rapidly. Patients with or at risk for MASH are underdiagnosed, and thus they may not be benefiting from newly approved liver-directed therapies that can alter the disease course. In this “Test and Teach” style symposium, attendees will be challenged to answer clinical questions about realistic patient cases presented by expert faculty. Faculty will provide real-time feedback on clinical decision-making and “teach” on important topics, including the interconnections between MASH and other chronic metabolic diseases, noninvasive testing strategies, risk stratification, and the latest clinical data on newly approved and emerging treatments for MASH. Join us for this fun and informative case challenge!
Speaker:
Fernando Bril, MD
MODERATOR
Assistant Professor
Department of Medicine
Division of Endocrinology, Diabetes, and Metabolism
University of Alabama at Birmingham
Birmingham, Alabama
Meena B. Bansal, MD, FAASLD
FACULTY
Professor of Medicine
Director of Translational Research, Liver Diseases
Icahn School of Medicine at Mount Sinai
New York, New York
Christos S. Mantzoros, MD, DSc, PhD
FACULTY
Professor of Medicine
Harvard Medical School
Boston University School of Medicine
Boston, Massachusetts